title: Reopening of a Full-Thickness Macular Hole 2 Years After Pharmacologic Closure With Ocriplasmin.
authors.affiliation: Retina Service, Wills Eye Hospital, Mid Atlantic Retina, Philadelphia, Pennsylvania.
authors.forename: Mohammed Ali
authors.initials: MA
authors.lastname: Khan
authors.affiliation: Retina Service, Wills Eye Hospital, Mid Atlantic Retina, Philadelphia, Pennsylvania.
authors.forename: Abtin
authors.initials: A
authors.lastname: Shahlaee
authors.affiliation: Retina Service, Wills Eye Hospital, Mid Atlantic Retina, Philadelphia, Pennsylvania.
authors.forename: Allen C
authors.initials: AC
authors.lastname: Ho
mesh_terms: D000368:Aged; D005341:Fibrinolysin / Q000627:therapeutic use*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010446:Peptide Fragments / Q000627:therapeutic use*; D012008:Recurrence; D012167:Retinal Perforations / Q000175:diagnosis* / Q000188:drug therapy* / Q000503:physiopathology; D013997:Time Factors; D041623:Tomography, Optical Coherence; D014792:Visual Acuity; D014945:Wound Healing / Q000502:physiology
chemical_list: D005343:Fibrinolytic Agents; D010446:Peptide Fragments; C054561:microplasmin; D005341:Fibrinolysin